Skip to content

Mani Mohindru, Chief Executive Officer at Cardiff Oncology, bought CRDF on Jun 18, 2026

Data as of Oct 16

▲ BUY$29.9K24,703 shares at $1.21Mani Mohindru Chief Executive OfficerCRDF Cardiff Oncology, Inc.
Watch CRDF
Traded
Jun 18, 2026
Disclosed
Jun 22, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Mani Mohindru, Chief Executive Officer at Cardiff Oncology, bought CRDF on Jun 18, 2026TRADEDDISCLOSED
CRDFSimilar stocks (XLV — its sector index fund), rebased to CRDF's price on the disclosure day
CRDF since disclosure
−30.7%
Similar stocks (XLV) since disclosure
+17.8%
XLV — its sector index fund

Change in closing price from Jun 22, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on CRDF →